Disability Timeline for Progressive Multiple Sclerosis (MS)
Topic: Multiple Sclerosis (MS)
Author: Mayo Clinic
Published: 2011/04/15 - Updated: 2022/04/21
Contents: Summary - Introduction - Main Item - Related Topics
Synopsis: By noting the presence of markers in a diagnostic test, researchers predict whether patients will suffer faster onset of disability and counsel them to help ease anxiety. For this study, researchers analyzed CSF test results and noticed a relationship between a faster disability rate and abnormally high levels of two proteins - oligoclonal band and immunoglobulin-G molecule. MS is the most common cause of non-traumatic neurological disability in young adults in North America and Europe. MS occurs most often in people ages 20 to 40, and is up to three times more common in women than men.
Introduction
Many patients with progressive multiple sclerosis (MS) worry how quickly the disease will progress. Now, by noting the presence of certain markers in a commonly performed diagnostic test, Mayo Clinic researchers can predict whether patients will suffer a faster onset of disability and counsel them to help ease anxiety. The research is being presented at the American Academy of Neurology meeting in Honolulu, Hawaii.
Main Item
Progressive MS is a disease of the central nervous system that can damage the brain, spinal cord and optic nerves. Over time, this damage can make it difficult or impossible for patients to walk, making them reliant on mobility aids such as walkers or wheelchairs.
"In this study, we found that in patients who developed the progressive form of MS that had preceding relapses, the presence of greater production of one of these molecules, immunoglobulin G, predicted a faster onset of disability," explains Orhun Kantarci, M.D., a Mayo Clinic neurologist and the study's lead author.
As physicians better predict the onset of disability, they can better counsel patients by providing answers in a time of uncertainty.
The study looked at cerebrospinal fluid (CSF) test results from a sample of 281 progressive MS patients seen at Mayo Clinic from 2002 to 2007. In general, CSF test results help physicians when the diagnosis is uncertain.
For this study, researchers analyzed CSF test results and noticed a relationship between a faster disability rate and abnormally high levels of two proteins - oligoclonal band and immunoglobulin-G molecule. If patients had the progressive form of MS with proceeding relapses, and their CSF results showed an elevated protein, researchers concluded they will have a faster rate of disability.
The study is a significant step forward in predicting disability outcomes, says researcher Junger Tang, M.D., a neurology fellow at Mayo Clinic. The next step is further research to confirm the results, he says.
MS is the most common cause of non-traumatic neurological disability in young adults in North America and Europe. MS occurs most often in people ages 20 to 40, and is up to three times more common in women than men. Symptoms include weakness, loss of sensation, visual disturbances, and cognitive dysfunction.
Attribution/Source(s):
This quality-reviewed publication was selected for publishing by the editors of Disabled World due to its significant relevance to the disability community. Originally authored by Mayo Clinic, and published on 2011/04/15 (Edit Update: 2022/04/21), the content may have been edited for style, clarity, or brevity. For further details or clarifications, Mayo Clinic can be contacted at mayoclinic.org. NOTE: Disabled World does not provide any warranties or endorsements related to this article.
Explore Related Topics
1 - New Multiple Sclerosis Treatment Clinical Trial Begins Enrollment - Clinical trial of Autologous Hematopoietic Stem Cell Transplantation versus Best Available Therapy for Multiple Sclerosis (BEAT-MS) begins enrollment.
2 - Stigma Increases Risk of Depression for People with Multiple Sclerosis - Those with MS who feel stigmatized are more likely to have depression, having a support system of friends and family and a sense of autonomy may help reduce the harmful effects of stigma..
3 - $7M MS Progression Cohort to Research Multiple Sclerosis in Canada - Research proposals will invite researchers to establish a Canadian cohort of people living with MS to study progression in the disease.
4 - How Can We Predict Whose Multiple Sclerosis Will Worsen? - Multiple Sclerosis study brings us closer to understanding which older adults with MS may be at higher risk of getting worse.
5 - Cladribine Significantly Reduces Brain Atrophy in Patients with Multiple Sclerosis - Phase III CLARITY study data revealed significant reduction in brain atrophy in patients on short course of investigational Cladribine Tablets over two years.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): Mayo Clinic. (2011, April 15 - Last revised: 2022, April 21). Disability Timeline for Progressive Multiple Sclerosis (MS). Disabled World. Retrieved October 14, 2024 from www.disabled-world.com/health/autoimmunediseases/ms/ms-timeline.php
Permalink: <a href="https://www.disabled-world.com/health/autoimmunediseases/ms/ms-timeline.php">Disability Timeline for Progressive Multiple Sclerosis (MS)</a>: By noting the presence of markers in a diagnostic test, researchers predict whether patients will suffer faster onset of disability and counsel them to help ease anxiety.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.